AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise for Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether adding lenalidomide to a standard chemotherapy regimen (MEC) could help adults with acute myeloid leukemia (AML) that either did not respond to initial treatment or came back after treatment. The trial enrolled 41 people aged 18 to 70. The main goal was …
Matched conditions: AML
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
New drug ZE46-0134 tested in healthy people for first time
Knowledge-focused CompletedThis study tested a new drug called ZE46-0134 in 112 healthy adults to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. This early research helps doctors understand the right dose and any side effects before testing…
Matched conditions: AML
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:01 UTC